BriaCell Therapeutics Corp Warrant
BCTXZ
5 hedge funds and large institutions have $61.7K invested in BriaCell Therapeutics Corp Warrant in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
25% more funds holding
Funds holding: 4 → 5 (+1)
33.74% less ownership
Funds ownership: 60.84% → 27.1% (-34%)
69% less capital invested
Capital invested by funds: $199K → $61.7K (-$137K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.1K |
| 2 |
HF
HRT Financial
New York
|
+$6.61K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$1.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Empery Asset Management
New York
|
-$93.3K |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
-$22.1K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$8.36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$658 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Heights Capital Management
San Francisco,
California
| $31.3K | -$22.1K | -226,719 | -42% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $11.5K | -$8.36K | -85,951 | -42% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $11.5K | +$11.1K | +114,522 | New |
|
|
HF
4
HRT Financial
New York
| $6K | +$6.61K | +67,935 | New |
|
|
TSS
5
Two Sigma Securities
New York
| $1.43K | +$1.47K | +15,060 | New |
|
|
EAM
6
Empery Asset Management
New York
| – | -$93.3K | -666,600 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$658 | -4,697 | Closed |
|
BCTXZ Hedge Fund Activity: Q2 2026 in Review
5 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXZ) for Q2 2026, worth a combined $61.7K — down 69% from $199K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BCTXZ positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $11.1K. The largest seller was Empery Asset Management, exiting entirely with an estimated $93.3K sold.
- 5 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXZ) as of Q2 2026, up from 4 in Q1 2026.
- Funds reported $61.7K of BriaCell Therapeutics Corp Warrant stock for Q2 2026, down 69% quarter-over-quarter.
- 3 funds opened new BriaCell Therapeutics Corp Warrant positions in Q2 2026 and 2 closed out, a net change of +1 holder.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2026 was Susquehanna International Group, an estimated $11.1K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q2 2026 was Empery Asset Management, an estimated $93.3K sold.
Based on aggregated 13F filings for Q2 2026.